Penile NO release test (PNORT) has been designed to try to evaluate clinically the penile endothelial function (PEF). The shear-stress flow-mediated vasodilation (FMD) of the cavernous arteries is evaluated in two groups of patients with neurogenic (n¼23) and vasculogenic (n¼23) erectile dysfunction (ED) by measuring their percent of increase after a 5 min occlusion of the flow. Both groups show an important FMD decrease (17.78711.78 and 17.82713%) as compared to the agematched control group (n¼12) (65.14730.5%, Po0.001). In the vasculogenic and control groups, mean FMD is lower in patients with one or more arterial risk factors(41 vs 67%, P¼0.025), and show a positive correlation with the plasmatic levels of bioavailable testosterone (r¼0.37, P¼0.03) and of DHEA-S (r¼0.46, P¼0.014). Patients achieving full erection at pharmacological test with visual sexual stimulation have a higher FMD (43.8738%) than those who did not (18.52714.37%, P¼0.008). We confirm clinically that PEF is strongly impaired in organic ED linked to neurological, vascular and endocrine factors.
Introduction
Nitric oxide (NO) is recognised to be a predominant player in the cascade of biochemical events producing an erection. 1 Recent experimental studies emphasised the importance of endothelial NO synthetase (eNOS) in maintaining the erection elicited by the neural NO synthetase (nNOS). 2 Relaxation of the smooth muscle and shear-stress flow-mediated vasodilation (FMD) through the phosphatidyl inositol 3-kinase/akt pathway produce NO continuously in order to maintain erection. Erectile dysfunction (ED) is frequently secondary to veno-occlusive disease (VOD) attributed to an impairment of the endothelium in producing NO. Nevertheless, to date, no test is available to evaluate in clinical practice the penile endothelial function (PEF). However, it has been demonstrated that NO is responsible for flow-dependent dilation of the peripheral conduit arteries. 3 The test consists in evaluating the flow and diameter increase in the arteries of the upper limb after an occlusion of the flow for 3-5 min. It is currently used to study the endothelial function in patients at risk of cardiovascular disease. 4 Other studies explain that local vascular characteristics may induce variations in the response. 5 Thus, we decided to explore the penile response to FMD. In a preliminary study, 6 including 95 subjects (22 with normal erections and 73 with various aetiologies of ED), we measured the internal diameter of one of the cavernous arteries before and after an occlusion of the penile flow for 5 min. The FMD expressed in percent of increase of arterial diameter varied from 0 to 152%. Significant statistical differences were observed between predominant organic ED and both the psychological and control group. The critical value was set at 40% (95% confidence interval) provided that, above it, no significant organic patients were observed. These results suggest that organic ED is related to a local decrease of the endothelial function as compared to psychological ED and normal erection. The test, strictly noninvasive could become a reliable tool to evaluate the functional status of the cavernous bodies. We propose to call it the penile NO release test (PNORT).
The purpose of the present work is to evaluate the PNORT in well-defined groups of patients where endothelial dysfunction is suspected for neurological or vascular reasons, and also the influence of age, the presence of arterial risk factors (ARF) including smoking habits, hypertension, diabetes and hypercholesterolemia, and hormonal levels.
Methods

Patients
The study group (n¼58) was selected among 175 men attended to between January and June 2002 for various sexual disorders. Clinical interviews including the responses to the IIEF-5 questionnaire differentiate a non-ED control group (n¼35) from ED patients (n¼140). The control group consisted of 25 men with premature ejaculation and 10 with penile curvature without ED. From this population, 12 from the control group and 46 from the ED group were randomly assigned to test PNORT. Among those with ED clinical and multidisciplinary evaluation, 7 two subsets of patients were selected: neurologic (group N) consisting in 23 patients with an ED resulting from radical prostatectomy (n¼20), pelvic fracture (n¼2), multiple sclerosis (n¼1); and vasculogenic (n¼23) (group V) selected upon the results of duplex scan and pharmacological test with visual sexual stimulation (VSS) as described previously 7 (10 are predominantly arterial with an initial intracavernous flow o10 ml/min and a peak systolic cavernous velocity o20 mHz; and 13 have an additional cavernovenous leak with elevated end diastolic velocity 10 min after the injection and a quick fall of rigidity 1 min after stopping the VSS). The response to the pharmacological test with VSS gave full erection in 30 patients (65%) and tumescence without rigidity in 16 (35%). In 31 patients belonging to control and V groups, total testosterone (TT), bioavailable testosterone (BT) and DHEA sulfate (DHEA-S) were determined.
Methods
All selected patients underwent a PNORT after resting supine for 10 min. The diameter of one of the cavernous arteries is measured manually with the duplex-scan Dö ppler using a 13 mHz probe (baseline diameter¼BD). A 5 cm wide cuff is applied on the penis and inflated at a supra systolic pressure for 5 min. Measurements are made above the superior edge of the cuff. The postocclusive measurements are carried out 60-120 s after releasing the pressure at a fixed angle of the probe (post occlusive diameter¼POD). In each instance, three to five measurements are made along the artery and then averaged to get FMD¼(PODÀBD)/BD Â 100. For 10 patients a repeated PNORT was performed within the next months, seven without and three after initiating an intracavernous injection therapy. They were tested in the same conditions except for one who had stopped smoking. The control group was screened to evaluate influence of age, ARF, TT, BT and DHEA-S. To compare means of the three groups, ages of the control group were matched to both groups N and V (Table 1 ). In addition, potential correlation between FMD and ARF, TT, BT, DHEA-S within the control and V groups.
Statistical studies were carried out using the STATISTICA software. Comparison of means was carried out by one-way ANOVA using Scheffé's and Turkey's tests. Correlations were established by simple linear regression, other data were studied by using the t-test.
Results
The control group (median age 56 y) did not show any statistical difference or correlation of FMD for age ARF, TT and BT, but a strong correlation (r¼0.92) in the six cases where DHEA-S was determined. Table 1 gives the detailed comparative results in the three groups showing a strong statistical difference (Po0.001) for FMD between the age-matched control group and groups N and V. Both ED groups showed an important and similar decrease of FMD. In the control and V groups mean FMD is significantly lower (P¼0.025) when one or more ARF are (Figure 1) . With the pharmacological test with VSS, FMD showed a strong difference (P¼0.008) between patients achieving full erection (43.8738%) and those who had only tumescence (18.52714.37%). In the seven untreated cases when PNORT was repeated, FMD showed similar results in a range of less than 10% variation in six patients. One patient had a 15% increase over the initial result, probably caused by the cessation of smoking 2 h prior the exam as compared to the 10 cigarettes he had smoked prior to the first test. Two of the three patients initiating an ICI treatment had an increase of 15 and 20% of FMD at the 1 and 3 months visit. One of the two postradical prostatectomy patients was unchanged, the ICI treatment being successful in all three cases.
Discussion
This study confirms the preliminary results 6 giving more reliability for PNORT to become a useful test in day to day screening of ED. No patients of this new study with an FMD above 40% had a predominant organic aetiology. The evidence of a low variability in repeated measurements is supported by observations in upper limb determination of FMD 8 . In the preliminary study, a negative correlation has been observed between FMD and BD. This needs further evaluation of the variation of BD in larger series. One could choose to study if POD-BD would be a better index than the percent increase. The very low FMD observed in the two groups N and V confirms the experimental explanation proposed for neurogenic and vasculogenic ED: the diminished NO synthesis in the penis. However, mechanisms of ED being different in neurogenic and vasculogenic, one would have expected differences in FMD values. Being equally low, the results confirm that PNORT measures the capacity of the erectile tissue to produce NO whatever the aetiology or the mechanism of ED is. Explanation could lie on the double action of nNOS and eNOS: neurologic ED being mediated by a decreased production of nNOS and vasculogenic ED by a lack of eNOS, according to recent experimental findings. 2 Both would result in a decrease reactivity to the test. Another fact is that the lowest FMD was observed in patients having the weakest response to ICI. The negative influence of the ARF on FMD also confirms their local negative impact on the endothelial function. Whether this is generalised and/or localised to the penis should be studied by comparative measurements of FMD at both the upper limb and penile level. Findings of a potential influence of BT on FMD are supported by a previous report of a direct relation between free testosterone and cavernous vasodilation 9 in patients with ED of arterial origin. On the other hand, if confirmed on a larger series, the correlation between low DHEA-S and low FMD will provide an explanation of its value as a predictive parameter of ED in epidemiological studies. PNORT could also become an easy way to control the efficacy of the different medical treatments at the penile level objectively, as is suggested by the improvement of FMD in two of the three controlled cases. Further studies aim at studying the influence of ARF on non-ED population; the impact of sexual stress on local FMD, as it has been shown that mental stress may impair upper limb's FMD; 10 the exact correlations between VOD and endothelial function. Thus, being fully noninvasive, technically easy to perform, PNORT could become a major clinical test to study erection and ED. The penile NO release test (PNORT) R Virag et al
